Final overall survival (OS) in patients (pts) with newly diagnosed advanced ovarian cancer (aOC) treated with niraparib (nir) first-line (1L) maintenance: Results from PRIMA/ENGOT-OV26/GOG-3012 Meeting Abstract
| Authors: | González-Martín, A.; Pothuri, B.; Ginesta, M. P. B.; Graybill, W. S.; Vergote, I. B.; McCormick, C.; Mirza, M. R.; Moore, R. G.; Lorusso, D.; O'Cearbhaill, R. E.; Freyer, G.; O'Malley, D. M.; Heitz, F.; Shahin, M. S.; Bruchim, I.; Bradley, W. H.; Compton, N.; Malinowska, I.; Redondo, A.; Monk, B. J. |
| Abstract Title: | Final overall survival (OS) in patients (pts) with newly diagnosed advanced ovarian cancer (aOC) treated with niraparib (nir) first-line (1L) maintenance: Results from PRIMA/ENGOT-OV26/GOG-3012 |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sept 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | 1222 |
| End Page: | 1223 |
| Language: | English |
| ACCESSION: | WOS:001326612903037 |
| DOI: | 10.1016/j.annonc.2024.08.2268 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA29 -- Source: Wos |
